The Economic Benefits of Pharmaceutical Innovations: The Case of Cox-2 Inhibitors
Download full text from publisher
References listed on IDEAS
- Duggan, Mark, 2005. "Do new prescription drugs pay for themselves?: The case of second-generation antipsychotics," Journal of Health Economics, Elsevier, vol. 24(1), pages 1-31, January.
- Harsha Thirumurthy & Joshua Graff Zivin & Markus Goldstein, 2008.
"The Economic Impact of AIDS Treatment: Labor Supply in Western Kenya,"
Journal of Human Resources,
University of Wisconsin Press, vol. 43(3), pages 511-552.
- Harsha Thirumurthy & Markus Goldstein & Joshua Graff Zivin, 2005. "The Economic Impact of AIDS Treatment: Labor Supply in Western Kenya," Working Papers id:300, eSocialSciences.
- Harsha Thirumurthy & Joshua Graff-Zivin & Markus Goldstein, 2005. "The Economic Impact of AIDS Treatment: Labor Supply in Western Kenya," NBER Working Papers 11871, National Bureau of Economic Research, Inc.
- Harsha Thirumurthy & Joshua Graff Zivin & Markus Goldstein, 2006. "The Economic Impact of AIDS Treatment: Labor Supply in Western Kenya," Working Papers 947, Economic Growth Center, Yale University.
- Joseph P. Newhouse, 1992. "Medical Care Costs: How Much Welfare Loss?," Journal of Economic Perspectives, American Economic Association, vol. 6(3), pages 3-21, Summer.
- Steven Haider & David Loughran, 2001. "Elderly Labor Supply: Work or Play?," Working Papers 01-09, RAND Corporation.
- Bartel, Ann & Taubman, Paul, 1979. "Health and Labor Market Success: The Role of Various Diseases," The Review of Economics and Statistics, MIT Press, vol. 61(1), pages 1-8, February.
- Berndt, Ernst R. & Finkelstein, Stan N. & Greenberg, Paul E. & Howland, Robert H. & Keith, Alison & Rush, A. John & Russell, James & Keller, Martin B., 1998. "Workplace performance effects from chronic depression and its treatment," Journal of Health Economics, Elsevier, vol. 17(5), pages 511-535, October.
- Steven Haider & David S Loughran, 2001. "Elderly Labor Supply Work or Play?," Working Papers DRU-2582, RAND Corporation.
Blog mentionsAs found by EconAcademics.org, the blog aggregator for Economics research:
- “The Economic Benefits of Pharmaceutical Innovations: The Case of Cox-2 Inhibitors,” C. Garthwaite (2012)
by afinetheorem in A Fine Theorem on 2013-03-20 12:37:41
CitationsCitations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
- Johanna Catherine Maclean & Lauren Hersch Nicholas & Keshar M. Ghimire, 2017.
"The Impact of State Medical Marijuana Laws on Social Security Disability Insurance and Workers' Compensation Benefit Claiming,"
- Johanna Catherine Maclean & Keshar M. Ghimire & Lauren Hersch Nicholas, 2017. "The Effect of State Medical Marijuana Laws on Social Security Disability Insurance and Workers' Compensation Claiming," NBER Working Papers 23862, National Bureau of Economic Research, Inc.
- Rodrigo Camejo & Clare McGrath & Marisa Miraldo & Frans Rutten, 2014. "Distribution of health-related social surplus in pharmaceuticals: an estimation of consumer and producer surplus in the management of high blood lipids and COPD," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(4), pages 439-445, May.
- BÃ¼tikofer, A. & Skira, M., 2015. "Missing work is a pain: the effect of Cox-2 inhibitors on sickness absence and disability pension receipt," Health, Econometrics and Data Group (HEDG) Working Papers 15/13, HEDG, c/o Department of Economics, University of York.
- Lauren Hersch Nicholas & Johanna Catherine Maclean, 2016. "The effect of medical marijuana laws on the health and labor supply of older adults: Evidence from the Health and Retirement Study," NBER Working Papers 22688, National Bureau of Economic Research, Inc.
- Moore, Timothy J., 2015.
"The employment effects of terminating disability benefits,"
Journal of Public Economics,
Elsevier, vol. 124(C), pages 30-43.
- Timothy J. Moore, 2014. "The Employment Effect of Terminating Disability Benefits," NBER Working Papers 19793, National Bureau of Economic Research, Inc.
- Timothy J. Moore, 2015. "The Employment Effects of Terminating Disability Benefits," Melbourne Institute Working Paper Series wp2015n02, Melbourne Institute of Applied Economic and Social Research, The University of Melbourne.
- Collins, J. Michael & Simon, Kosali I. & Tennyson, Sharon, 2013. "Drug withdrawals and the utilization of therapeutic substitutes: The case of Vioxx," Journal of Economic Behavior & Organization, Elsevier, vol. 86(C), pages 148-168.
More about this item
- I12 - Health, Education, and Welfare - - Health - - - Health Behavior
- J22 - Labor and Demographic Economics - - Demand and Supply of Labor - - - Time Allocation and Labor Supply
- L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology; Plastics
- O31 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Innovation and Invention: Processes and Incentives
ListsThis item is featured on the following reading lists or Wikipedia pages:
- The Economic Benefits of Pharmaceutical Innovations: The Case of Cox-2 Inhibitors (AEJ:AE 2012) in ReplicationWiki
StatisticsAccess and download statistics
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:aea:aejapp:v:4:y:2012:i:3:p:116-37. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Jane Voros) or (Michael P. Albert). General contact details of provider: http://edirc.repec.org/data/aeaaaea.html .
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
Please note that corrections may take a couple of weeks to filter through the various RePEc services.